Compounds > 3,5-dihydroxyphenylglycine
Page last updated: 2024-09-02

3,5-dihydroxyphenylglycine and Fatty Liver

3,5-dihydroxyphenylglycine has been researched along with Fatty Liver in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Berardo, C; Cagna, M; Di Pasqua, LG; Ferrigno, A; Richelmi, P; Siciliano, V; Vairetti, M1

Other Studies

1 other study(ies) available for 3,5-dihydroxyphenylglycine and Fatty Liver

ArticleYear
The selective blockade of metabotropic glutamate receptor-5 attenuates fat accumulation in an in vitro model of benign steatosis.
    European journal of histochemistry : EJH, 2020, Nov-10, Volume: 64, Issue:4

    Topics: Fatty Liver; Glycine; Hep G2 Cells; Humans; PPAR alpha; Pyridines; Receptor, Metabotropic Glutamate 5; Resorcinols; Sterol Regulatory Element Binding Protein 1; Triglycerides

2020